AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Healius (ASX:HLS) Surges After Announcing Lucrative Dividend Post-Subsidiary Sale
March 27, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Healius (ASX:HLS) shares surged 14.5% following a special dividend announcement.,The dividend is announced after the $300 million sale of Lumus Imaging.,Shareholders to receive a full-franked special dividend of $4.13 per share.,Pathology...
Clinuvel Pharmaceuticals Announces Extended Share Repurchase Initiative
March 27, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Clinuvel Pharmaceuticals (CUV) extends its share repurchase program for another year.,Plans to repurchase an additional 1.5 million shares, about 3% of the outstanding share capital.,The initiative highlights Clinuvel’s commitment to sound...
The morning catch up: ASX on the green as small and mid cap companies present their wares at the ASX SMIDcaps Conference
March 26, 2025 07:32 PM AEDT| By Team Kalkine MediaHighlights:,ASX 200,records a steady performance amid sector shifts.,Healthcare Stocks,gain traction with new product launches.,Small and mid-cap companies showcase innovations at the ASX SMIDcaps Conference.,The,ASX 200,maintained stability with sec...
Prescient Therapeutics opens first clinical site for Phase 2a PTX-100 trial in cutaneous T-cell lymphoma
March 26, 2025 07:29 PM AEDT| By Team Kalkine MediaHighlights,Prescient Therapeutics Ltd (ASX,:PTX,, OTC,:PSTTF,),initiates a Phase 2a clinical trial for PTX-100 in cutaneous T-cell lymphoma.,The first study site has been established at Epworth Freemasons Haematology Clinical Trial Unit.,PTX-100 is a...
Clinuvel's Stroke Drug Trial Reports Positive Findings
March 26, 2025 06:34 PM AEDT| By Team Kalkine MediaHighlights:,ASX 200, Healthcare Stocks,gain attention as Clinuvel (ASX:CUV) reports trial progress.,Stroke drug,PRENUMBRA,demonstrates a favorable safety profile.,Clinical data aligns with prior research on afamelanotide.,Clinuvel Pharmaceuticals (AS...
Top of mind: ASX companies tackling neurological disorders
March 26, 2025 06:24 PM AEDT| By Team Kalkine MediaHighlights:,Several,ASX 200,healthcare stocks are focusing on treatments for neurological disorders.,The neurological drug development landscape is evolving with new clinical trials.,Regulatory advancements are fostering growth in research for brain-...
Assessing Pro Medicus as a Defensive ASX Stock
March 26, 2025 05:42 PM AEDT| By Team Kalkine MediaAssessing Pro Medicus as a Defensive ASX Stock
Groundbreaking Advancements: Prescient Therapeutics (ASX:PTX) Launches Phase 2a Trial for Novel CTCL Therapy
March 26, 2025 02:30 PM AEDT| By Team Kalkine MediaHighlights,Prescient Therapeutics (,ASX:PTX,) has,initiated,a Phase 2a study of PTX-100.,The study will evaluate the efficacy and safety of PTX-100 in CTCL patients.,Sites across Australia, the USA, and Europe are set to,participate,.,Prescient Thera...
LTR Pharma Expands into the U.S. Market with Roxus Nasal Spray
March 26, 2025 02:30 PM AEDT| By Team Kalkine MediaLTR Pharma Expands into the U.S. Market with Roxus Nasal Spray
Orthocell Expands Striate+ Sales into DACH Region Amid Growing Global Demand
March 26, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlight:,Striate+ enters Germany, Austria, and Switzerland following strong EU and UK traction,Distribution partner BioHorizons Camlog initiates first sales in the DACH region,Clinical success and surgeon feedback underpin rapid global expansion st...
Clinuvel's Stroke Treatment Study Shows Promising Results
March 26, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Significant functional improvement observed in stroke trial participants.,Majority show positive radiological outcomes.,Clinuvel (CUV) optimistic about afamelanotide's safety and effectiveness.,Clinuvel (ASX:CUV) recently announced encoura...
Streamlining for Success: 4DMedical Limited (ASX:4DX) Launches Major Cost Reduction Initiative
March 26, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Substantial Cost Cuts:,4DMedical Limited (4DX) announces $6.5 million in annual savings.,Financial Resilience:,Despite cost cuts, the company maintains a strong financial outlook with significant capital from recent funding rounds.,Leaders...
LTR Pharma (ASX:LTP) Expands Horizons with FDA Endorsement and New Product Launch
March 26, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,LTR Pharma secures FDA endorsement for SPONTAN® development.,Launch of Roxus® aims to tap into the US personalized healthcare market.,SPONTAN® earns scientific accolades for rapid absorption and efficacy.,LTR Pharma Limited (ASX:LTP) is ma...
Orthocell Pioneers Expansion with Striate+ in Central Europe
March 26, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Orthocell (OCC) marks its first sales of Striate+ in the DACH region.,Positive clinical outcomes boost the product's market acceptance.,Strong financials support strategic expansions into new markets.,Orthocell Limited (ASX:OCC) has succes...
Expanding Horizons: Orthocell’s Striate+ Makes Groundbreaking Entry into European Markets
March 26, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Orthocell (ASX: OCC) ventures into Germany, Austria, and Switzerland with Striate+.,Significant revenue potential eyed with a targeted market share in a billion-dollar industry.,Positive feedback and high success rates propel demand for in...
Vanguard's Latest US Market ETF Distribution: Key Dates and Details
March 26, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Final distribution announced for (ASX:VTS) holders.,Key dates from ex-distribution to payment detailed.,Important information on CDI cancellation requests.,Vanguard Investments Australia Ltd recently announced a final distribution for the...
ASX Stocks Gaining Attention Amid Market Fluctuations
March 25, 2025 05:56 PM AEDT| By Team Kalkine MediaASX Stocks Gaining Attention Amid Market Fluctuations
Immutep makes progress with first lung cancer patient dosing
March 25, 2025 03:31 PM AEDT| By Team Kalkine MediaImmutep makes progress with first lung cancer patient dosing
Aroa Biosurgery (ARX) Is Well-Positioned for Business Growth
March 25, 2025 03:31 PM AEDT| By Team Kalkine MediaAroa Biosurgery (ARX) Is Well-Positioned for Business Growth
Immutep Limited (ASX:IMM) Launches Major Phase III Trial Targeting Lung Cancer
March 25, 2025 03:06 PM AEDT| By Team Kalkine MediaHighlights,Immutep Limited (IMM) begins pivotal Phase III trial for lung cancer treatment.,The global study aims to enroll over 750 patients in 25+ countries.,Potential for setting a new standard of care in treating advanced lung cancer.,In a signifi...
Advertise your brand on Kalkine Media